Sanoudou D, Beggs A H
Division of Genetics, Children's Hospital, Harvard Medical School, 300 Longwood Ave., Boston, MA 02115, USA.
Trends Mol Med. 2001 Aug;7(8):362-8. doi: 10.1016/s1471-4914(01)02089-5.
The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.
杆状体肌病(NM)这一术语涵盖了一组原发性骨骼肌无力的异质性疾病,其特征是受影响个体的肌肉中存在杆状体。疾病严重程度各不相同且不可预测,预后范围从新生儿死亡到几乎正常的运动功能。在NM疾病基因识别方面的最新进展表明,NM是一种骨骼肌肌节疾病,尤其是细肌丝疾病。这些发现开始改变神经科医生和遗传学家诊断和为NM患者提供咨询的方法,并可能在未来带来对特定定向治疗的深入了解。